February 9, 2026 Company name: Tokyo Ohka Kogyo Co., Ltd. Listing: Tokyo Stock Exchange (Prime Market) Securities Code: 4186 URL: https://www.tok.co.jp/eng
Representative: Noriaki Taneichi, President and Chief Executive Officer
Inquiries: Daisuke Matsuyama, General Manager, Accounting Department TEL: +81-44-435-3000 Scheduled date of ordinary general meeting of shareholders: March 27, 2026
Scheduled date to commence dividend payments: March 30, 2026 Scheduled date to file annual securities report: March 24, 2026 Preparation of supplementary material on financial results: Yes
Holding of financial results briefing: Yes (for institutional investors and analysts)
(Yen amounts are rounded down to millions, unless otherwise noted.)
- Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (January 1, 2025 toDecember 31, 2025)
Consolidated Operating Results (% indicates the rate of increase/decrease year-on-year.)
Net sales
Operating income
Ordinary income
Profit attributable to owners of parent
Fiscal year ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
December 31, 2025
237,029
17.9
47,386
43.2
49,274
42.6
33,345
47.0
December 31, 2024
200,966
23.8
33,090
45.7
34,554
42.4
22,683
78.4
(Note) Comprehensive income: FY2025: ¥41,830 million [25.8%] FY2024: ¥33,259 million [37.3%]
Basic earnings per share
Diluted earnings per share
Return on equity
Ratio of ordinary income to total assets
Operating margin
Fiscal year ended
Yen
Yen
%
%
%
December 31, 2025
278.42
278.21
15.6
16.0
20.0
December 31, 2024
187.29
187.10
11.8
12.9
16.5
(Reference) Share of profit (loss) of investments accounted for using equity method : FY2025: ¥471 million FY2024: ¥(116) million
Consolidated Financial Position
Total assets
Net assets
Equity ratio
Net assets per share
As of
Millions of yen
Millions of yen
%
Yen
December 31, 2025
335,292
242,299
67.9
1,898.90
December 31, 2024
281,930
213,473
71.1
1,671.82
(Reference) Equity: As of December 31, 2025: ¥227,636 million As of December 31, 2024: ¥200,533 million
Consolidated Cash Flows
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period
Fiscal year ended
Millions of yen
Millions of yen
Millions of yen
Millions of yen
December 31, 2025
35,194
(25,291)
3,172
69,228
December 31, 2024
30,146
(2,733)
(15,424)
56,361
- Cash Dividends
Annual dividends per share
Total cash dividends
Payout ratio
Dividend on equity ratio
1stquarter
2nd quarter
3rd quarter
Year-end
Total
Fiscal year ended
Yen
Yen
Yen
Yen
Yen
Millions of yen
%
%
December 31, 2024
—
29.00
—
34.00
63.00
7,599
33.5
4.0
December 31, 2025
—
35.00
—
37.00
72.00
8,631
25.9
4.0
FY2026 (Forecast)
—
40.00
—
40.00
80.00
27.4
- Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2026 (January 1, 2026 to December 31, 2026) (% indicates the rate of increase/decrease against the same period of the previous year.)
Net sales | Operating income | Ordinary income | Profit attributable to owners of parent | Basic earnings per share | |||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |
First half | 125,000 | 12.0 | 24,300 | 22.4 | 25,500 | 25.1 | 16,000 | 17.5 | 133.47 |
Full year | 261,000 | 10.1 | 52,200 | 10.2 | 53,800 | 9.2 | 35,000 | 5.0 | 291.62 |
Significant changes in the scope of consolidation during the period: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes in accounting policies due to revisions to accounting standards and other regulations: None
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: None
Restatement: None
Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of December 31, 2025
127,800,000 shares
As of December 31, 2024
127,800,000 shares
Number of treasury shares at the end of the period
As of December 31, 2025
7,922,099 shares
As of December 31, 2024
7,851,327 shares
Average number of shares outstanding during the period
Fiscal year ended December 31, 2025 | 119,763,425 shares |
Fiscal year ended December 31, 2024 | 121,108,160 shares |
(Reference) Overview of Non-Consolidated Financial Results
Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (from January 1, 2025 to December 31, 2025)Non-Consolidated Operating Results (% indicates year-on-year changes.)
Net sales
Operating income
Ordinary income
Profit
Fiscal year ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
December 31, 2025
128,009
12.6
21,677
42.7
32,256
30.7
27,556
31.3
December 31, 2024
113,707
24.5
15,189
79.5
24,686
85.1
20,987
103.8
Basic earnings
per share
Diluted earnings
per share
Fiscal year ended
Yen
Yen
December 31, 2025
230.09
229.91
December 31, 2024
173.29
173.11
Non-Consolidated Financial Position
Total assets | Net assets | Equity ratio | Net assets per share | |
As of | Millions of yen | Millions of yen | % | Yen |
December 31, 2025 | 237,803 | 175,628 | 73.8 | 1,464.39 |
December 31, 2024 | 196,093 | 154,907 | 78.9 | 1,290.43 |
(Reference) Equity: As of December 31, 2025: ¥175,548 million As of December 31, 2024: ¥154,786 million
The Financial Results report is outside the scope of an audit by certified public accountants or an audit firm.
Explanation of the proper use of financial results forecast and other special notes
The financial results forecast stated in this report are based on the information available as of the date of the release of this report, and actual results may differ from the forecast due to a variety of factors.
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
○Table of contents of the attached document
Overview of Operating Results, Etc 2
Overview of Operating Results for the Fiscal Year Ended December 31, 2025 2
Overview of Financial Position as of December 31, 2025 2
Overview of Cash Flows for the Fiscal Year Ended December 31, 2025 3
Future Outlook 3
Basic Policy for Selection of Accounting Standards 4
Consolidated Financial Statements and Major Notes 5
Consolidated Balance Sheet 5
Consolidated Statement of Income and Consolidated Statement of Comprehensive Income 7
Consolidated Statement of Income 7
Consolidated Statement of Comprehensive Income 8
Consolidated Statement of Changes in Equity 9
Consolidated Statement of Cash Flows 11
Notes to Consolidated Financial Statements 13
(Notes Concerning Going Concern Assumption) 13
(Notes Concerning Consolidated Statement of Income) 13
(Notes Concerning Consolidated Statement of Cash Flows) 14
(Notes Concerning Segment Information, Etc.) 14
(Per Share Information) 15
- Overview of Operating Results, Etc.
- Overview of Operating Results for the Fiscal Year Ended December 31, 2025
Operating results for the fiscal year ended December 31, 2025
For the fiscal year ended December 31, 2025, the electronics market, which is the main customers for the Group’s products, saw steady growth in demand for generative AI-related products and for PCs backed by replacement trends while smartphone demand remained soft.
Amid such circumstances, the Group, with an aim to gain No.1 global market share of cutting-edge photoresists, has continued to pursue a thorough customer perspective. We also promoted strategic investments in anticipation of future growth in semiconductor demand, including the construction of a new photoresist manufacturing building in Koriyama Plant in Japan, while overseas, a new inspection building in Incheon, South Korea, was completed and construction of a new high-purity chemical manufacturing building was commenced at a site purchased in Pyeongtaek.
In addition, as part of our all-out effort to attain our long-term vision, “tok Vision 2030,” we made micro resist technology GmbH in Germany our wholly-owned subsidiary to strengthen our customer-oriented strategy in the European market and enhance our product portfolio by integrating the company’s technologies.
As a result, sales of both electronic functional materials and high-purity chemicals increased significantly, and for the fiscal year ended December 31, 2025, the Group posted net sales of ¥237,029 million (up 17.9% year-on-year). Also, driven primarily by higher sales of high value-added products and a one-off profit recorded in connection with the recognition of inventories such as development-related materials, the Group recorded operating income of ¥47,386 million (up 43.2% year-on-year) and ordinary income of ¥49,274 million (up 42.6% year-on-year). Profit attributable to owners of parent increased to ¥33,345 million (up 47.0% year-on-year) due to higher operating income and the recording of extraordinary income associated with the transfer of Equipment Business, and both net sales and profit have hit a record high.
Operating results by business segment are not disclosed, but net sales by division are as follows.
Net sales in the Electronic Functional Materials Division amounted to ¥124,700 million (up 16.0% year-on-year), net sales in the High-Purity Chemicals Division amounted to ¥109,400 million (up 19.6% year-on-year), and net sales in Other amounted to ¥2,928 million (up 48.3% year-on-year).
- Overview of Financial Position as of December 31, 2025
(Assets)
Total assets as of December 31, 2025 increased by ¥53,362 million from December 31, 2024 to ¥335,292 million.
Total current assets increased by ¥21,003 million from December 31, 2024 to ¥172,773 million mainly due to increases in cash and deposit of ¥11,915 million and in accounts receivable - trade of ¥5,321 million.
Total non-current assets increased by ¥32,358 million from December 31, 2024 to ¥162,518 million mainly due to an increase of ¥20,251 million in property, plant and equipment associated with capital investments. (Liabilities)
Total liabilities as of December 31, 2025 increased by ¥24,536 million from December 31, 2024 to ¥92,993 million mainly due to increases in bonds payable of ¥10,000 million and in long-term borrowings of ¥10,000 million.
(Net assets)
Total net assets as of December 31, 2025 increased by ¥28,826 million from December 31, 2024 to ¥242,299 million mainly due to increases in retained earnings of ¥25,071 million and in valuation difference on available-for-sale securities of ¥1,982 million.
As a result, the equity ratio as of December 31, 2025 stood at 67.9%.
- Overview of Cash Flows for the Fiscal Year Ended December 31, 2025
(Cash flows from operating activities)
Net cash provided by operating activities during the fiscal year ended December 31, 2025 increased by ¥5,048 million from a year earlier to ¥35,194 million mainly because cash inflow increased due to an increase in profit before income taxes despite an increase in income taxes paid.
(Cash flows from investing activities)
Net cash used in investing activities increased by ¥22,558 million from a year earlier to ¥25,291 million mainly because cash outflow increased due to purchase of property, plant and equipment.
(Cash flows from financing activities)
Net cash provided by financing activities was ¥3,172 million because cash inflow increased by ¥18,597 million from a year earlier mainly due to proceeds from long-term borrowings and proceeds from issuance of bonds.
As a result, cash and cash equivalents increased by ¥12,867 million from December 31, 2024 to ¥69,228 million.
(Reference) Cash flow indicators
FY2021
FY2022
FY2023
FY2024
FY2025
Equity ratio (%)
71.7
71.3
72.9
71.1
67.9
Equity ratio at market value (%)
125.7
101.3
149.6
150.3
207.6
Interest-bearing debt to cash flow ratio (%)
58.4
59.2
64.5
36.8
77.1
Interest coverage ratio (times)
272.3
258.8
210.1
348.4
208.8
Equity ratio: Equity/Total assets
Equity ratio at market value: Market capitalization/Total assets
Interest-bearing debt to cash flow ratio: Interest-bearing debt/Cash flow Interest coverage ratio: Cash flow/Interest payment
(Note 1) All ratios are calculated based on the financial figures on a consolidated basis.
(Note 2) Market capitalization is calculated based on the number of shares issued and outstanding excluding treasury shares.
(Note 3) Cash flow is derived from cash flows from operating activities.
(Note 4) Interest-bearing debt includes all liabilities recorded on the consolidated balance sheet that are subject to interest payment.
- Future Outlook
For FY2026, with the continued strong demand in the electronics market for generative AI-related products, particularly for data centers, we expect a significant year-on-year increase in both revenue and profit based on the anticipated growth in materials for advanced semiconductors, the usage status of the Group’s products, and the launch of operations of customers’ new plants.
In FY2026, toward the realization of tok Vision 2030 to become “The e-Material Global CompanyTM” contributing to a sustainable future through chemistry, the Group will accelerate the growth under “tok Medium-Term Plan 2027” launched in FY2025 by further promoting “Gain No.1 global market share of cutting-edge photoresists,” “Increase global share in all business fields with an eye on tok Vision 2030,” “Create businesses in new fields,” “Secure stable supplies of high-quality products,” “Improve employee engagement,” and “Establish a robust management foundation to realize tok Vision 2030.”
The foreign exchange rate is assumed to be $1= ¥150.
(Millions of yen, %)Fiscal year ended December 31, 2025 (Results)
Fiscal year ending December 31, 2026
(Forecast)
Year-on-year
Net sales
237,029
261,000
10.1
Operating income
47,386
52,200
10.2
Ordinary income
49,274
53,800
9.2
Profit attributable to owners of parent
33,345
35,000
5.0
- Overview of Operating Results for the Fiscal Year Ended December 31, 2025
- Basic Policy for Selection of Accounting Standards
The Group has adopted Japanese GAAP.
The Group is currently examining the potential application of International Financial Reporting Standards (IFRS) in light of the trend in convergence of Japanese GAAP and revisions to IFRS by taking into account the impact of the transition to IFRS and the response thereto on the management.
- Consolidated Financial Statements and Major Notes
- Consolidated Balance Sheet
(Millions of yen)
FY12/24
(As of December 31, 2024)
FY12/25
(As of December 31, 2025)
Assets
Current assets
Cash and deposits
59,047
70,962
Notes receivable - trade
1,001
1,479
Accounts receivable - trade
41,845
47,166
Securities
3,999
—
Merchandise and finished goods
12,602
14,910
Work in process
9,539
10,849
Raw materials and supplies
14,744
18,246
Other
9,079
9,248
Allowance for doubtful accounts
(90)
(90)
Total current assets
151,770
172,773
Non-current assets
Property, plant and equipment
Buildings and structures
92,964
98,853
Accumulated depreciation
(52,696)
(55,469)
Buildings and structures, net
40,267
43,383
Machinery, equipment and vehicles
70,271
76,212
Accumulated depreciation
(61,680)
(64,487)
Machinery, equipment and vehicles, net
8,591
11,724
Tools, furniture and fixtures
28,949
32,636
Accumulated depreciation
(21,959)
(24,092)
Tools, furniture and fixtures, net
6,989
8,543
Right-of-use assets
915
1,025
Accumulated depreciation
(480)
(498)
Right-of-use assets, net
434
527
Land
10,890
13,989
Construction in progress
22,769
32,025
Total property, plant and equipment
89,942
110,193
Intangible assets
1,811
1,834
Investments and other assets
Investment securities
22,146
31,912
Investments in capital
84
81
Long-term loans receivable
34
61
Retirement benefit asset
9,404
10,083
Deferred tax assets
1,333
1,635
Other
5,408
6,715
Allowance for doubtful accounts
(5)
—
Total investments and other assets
38,406
50,490
Total non-current assets
130,160
162,518
Total assets
281,930
335,292
(Millions of yen)
FY12/24
(As of December 31, 2024)
FY12/25
(As of December 31, 2025)
Liabilities
Current liabilities
Notes and accounts payable - trade
26,869
29,544
Short-term borrowings
4,442
383
Accounts payable - other
7,929
11,015
Income taxes payable
5,020
6,863
Advances received
150
242
Provision for bonuses
3,479
4,575
Provision for bonuses for directors (and other officers)
501
304
Other
5,709
6,443
Total current liabilities
54,104
59,373
Non-current liabilities
Bonds payable
—
10,000
Long-term borrowings
6,100
16,100
Deferred tax liabilities
5,021
5,082
Retirement benefit liability
280
359
Asset retirement obligations
82
69
Other
2,868
2,007
Total non-current liabilities
14,352
33,619
Total liabilities
68,456
92,993
Net assets
Shareholders' equity
Share capital
14,640
14,640
Capital surplus
15,612
15,899
Retained earnings
159,313
184,384
Treasury shares
(15,796)
(16,586)
Total shareholders’ equity
173,769
198,337
Accumulated other comprehensive income
Valuation difference on available-for-sale
securities
9,509
11,492
Foreign currency translation adjustment
13,649
14,103
Remeasurements of defined benefit plans
3,605
3,703
Total accumulated other comprehensive
income
26,764
29,299
Share acquisition rights
121
79
Non-controlling interests
12,818
14,583
Total net assets
213,473
242,299
Total liabilities and net assets
281,930
335,292
- Consolidated Statement of Income and Consolidated Statement of Comprehensive Income (Consolidated Statement of Income)(Consolidated Statement of Comprehensive Income)
(Millions of yen)
FY 12/24
(January 1, 2024 – December 31, 2024)
FY 12/25
(January 1, 2025 – December 31, 2025)
Net sales
200,966
237,029
Cost of sales
*1,*3127,521
*1,*3147,588
Gross profit
73,444
89,440
Selling, general and administrative expenses
*2,*340,353
*2,*342,054
Operating income
33,090
47,386
Non-operating income
Interest income
397
406
Dividend income
580
653
Share of profit of investments accounted for
using equity method
—
471
Foreign exchange gains
—
289
Subsidy income
328
403
Other
589
540
Total non-operating income
1,895
2,765
Non-operating expenses
Interest expenses
86
168
Commission expenses
24
230
Share of loss of investments accounted for using equity method
116
—
Loss on valuation of derivatives
35
360
Foreign exchange losses
98
—
Other
68
117
Total non-operating expenses
431
876
Ordinary income
34,554
49,274
Extraordinary income
Gain on change in equity
198
—
Gain on sale of non-current assets
22
11
Gain on sale of investment securities
508
245
Gain on receipt of contingent consideration
—
*41,422
Total extraordinary income
730
1,679
Extraordinary losses
Loss on change in equity
—
12
Impairment losses
—
283
Loss on retirement of non-current assets
122
364
Other
4
0
Total extraordinary losses
126
661
Profit before income taxes
35,158
50,292
Income taxes - current
8,343
12,291
Income taxes - deferred
(237)
(1,187)
Total income taxes
8,105
11,104
Profit
27,052
39,188
Profit attributable to non-controlling interests
4,369
5,843
Profit attributable to owners of parent
22,683
33,345
(Millions of yen)
FY 12/24
(January 1, 2024 – December 31, 2024)
FY 12/25
(January 1, 2025 – December 31, 2025)
Profit
27,052
39,188
Other comprehensive income
Valuation difference on available-for-sale
securities
(249)
1,982
Foreign currency translation adjustment
2,495
561
Remeasurements of defined benefit plans
3,959
97
Total other comprehensive income
6,206
2,641
Comprehensive income
33,259
41,830
Comprehensive income attributable to:
Owners of parent
28,440
35,880
Non-controlling interests
4,818
5,950
- Consolidated Statement of Changes in Equity
For the fiscal year ended December 31, 2024 (January 1, 2024 – December 31, 2024)
(Millions of yen)
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total
shareholders’
equity
Balance at beginning of period
14,640
15,315
143,630
(10,940)
162,646
Changes during period
Dividends of surplus
(7,001)
(7,001)
Profit attributable to owners of parent
22,683
22,683
Purchase of treasury shares
(5,507)
(5,507)
Disposal of treasury shares
296
650
947
Net changes in items other than
shareholders' equity
Total changes during period
—
296
15,682
(4,856)
11,122
Balance at end of period
14,640
15,612
159,313
(15,796)
173,769
Accumulated other comprehensive income
Share acquisition rights
Non-controlling interests
Total net assets
Valuation difference on available-for-sale securities
Foreign currency translation adjustment
Remeasurements of
defined benefit plans
Total accumulated other comprehensive income
Balance at beginning of period
9,759
11,603
(354)
21,007
140
11,684
195,480
Changes during period
Dividends of surplus
(7,001)
Profit attributable to owners of parent
22,683
Purchase of treasury shares
(5,507)
Disposal of treasury shares
(19)
927
Net changes in items other than
shareholders' equity
(249)
2,046
3,959
5,756
—
1,133
6,890
Total changes during period
(249)
2,046
3,959
5,756
(19)
1,133
17,993
Balance at end of period
9,509
13,649
3,605
26,764
121
12,818
213,473
For the fiscal year ended December 31, 2025 (January 1, 2025 – December 31, 2025)
(Millions of yen)
Shareholders' equity
Share capital
Capital surplus
Retained earnings
Treasury shares
Total
shareholders’
equity
Balance at beginning of period
14,640
15,612
159,313
(15,796)
173,769
Changes during period
Dividends of surplus
(8,274)
(8,274)
Profit attributable to owners of parent
33,345
33,345
Purchase of treasury shares
(1,502)
(1,502)
Disposal of treasury shares
286
712
999
Net changes in items other than
shareholders' equity
Total changes during period
—
286
25,071
(789)
24,568
Balance at end of period
14,640
15,899
184,384
(16,586)
198,337
Accumulated other comprehensive income
Share acquisition rights
Non-controlling interests
Total net assets
Valuation difference on available-
for-sale securities
Foreign currency translation adjustment
Remeasurements of
defined benefit plans
Total accumulated other comprehensive income
Balance at beginning of period
9,509
13,649
3,605
26,764
121
12,818
213,473
Changes during period
Dividends of surplus
(8,274)
Profit attributable to owners of parent
33,345
Purchase of treasury shares
(1,502)
Disposal of treasury shares
(42)
957
Net changes in items other than shareholders' equity
1,982
454
97
2,534
—
1,765
4,300
Total changes during period
1,982
454
97
2,534
(42)
1,765
28,826
Balance at end of period
11,492
14,103
3,703
29,299
79
14,583
242,299
- Consolidated Statement of Cash Flows
(Millions of yen)
FY 12/24
(January 1, 2024 – December 31, 2024)
FY 12/25
(January 1, 2025 – December 31, 2025)
Cash flows from operating activities
Profit before income taxes
35,158
50,292
Depreciation
8,333
8,807
Impairment losses
—
283
Increase (decrease) in allowance for doubtful
accounts
14
(5)
Increase in provision for bonuses
930
1,089
Increase (decrease) in provision for bonuses for directors (and other officers)
306
(197)
Increase in retirement benefit asset
(73)
(331)
Increase (decrease) in retirement benefit liability
85
(76)
Interest and dividend income
(977)
(1,059)
Interest expenses
86
168
Foreign exchange gains
(658)
(364)
Loss on valuation of derivatives
35
360
Share of loss (profit) of investments accounted for using equity method
116
(471)
Gain on sale of non-current assets
(22)
(11)
Loss on retirement of non-current assets
122
364
Gain on sale of investment securities
(508)
(245)
Gain on receipt of contingent consideration
—
(1,422)
(Gain) loss on change in equity
(198)
12
Increase in trade receivables
(7,842)
(5,207)
Increase in inventories
(3,115)
(6,809)
Increase in trade payables
5,874
2,208
(Decrease) increase in advances received
(53)
89
Other
(3,970)
(2,760)
Subtotal
33,642
44,712
Interest and dividends received
1,008
1,105
Interest paid
(86)
(158)
Income taxes paid
(4,418)
(10,465)
Net cash provided by operating activities
30,146
35,194
Cash flows from investing activities
Purchase of securities
(12,000)
—
Proceeds from redemption of securities
12,000
3,000
Purchase of property, plant and equipment
(24,570)
(24,762)
Proceeds from sale of property, plant and equipment
56
56
Purchase of intangible assets
(936)
(613)
Purchase of investment securities
(107)
(6,672)
Proceeds from sale of investment securities
921
393
Net decrease in time deposits
11,516
2,000
Proceeds from withdrawal of long-term time
deposits
12,000
—
Proceeds from settlement of contingent consideration
—
1,422
Other
(1,614)
(116)
Net cash used in investing activities
(2,733)
(25,291)
(Millions of yen)
FY 12/24
(January 1, 2024 – December 31, 2024)
FY 12/25
(January 1, 2025 – December 31, 2025)
Cash flows from financing activities
Proceeds from short-term borrowings
520
366
Repayments of short-term borrowings
(520)
(513)
Proceeds from long-term borrowings
—
10,000
Repayments of long-term borrowings
—
(3,900)
Proceeds from issuance of bonds
—
10,000
Purchase of treasury shares
(5,520)
(44)
Proceeds from sale of treasury shares
927
0
Dividends paid
(6,996)
(8,268)
Dividends paid to non-controlling interests
(3,685)
(4,184)
Other
(150)
(282)
Net cash (used in) provided by financing activities
(15,424)
3,272
Effect of exchange rate change on cash and cash
equivalents
1,585
(208)
Net increase in cash and cash equivalents
13,572
12,867
Cash and cash equivalents at beginning of period
42,788
56,361
Cash and cash equivalents at end of period
*56,361
*69,228
- Notes to Consolidated Financial Statements (Notes Concerning Going Concern Assumption)
- Consolidated Balance Sheet
Not applicable.
(Notes Concerning Consolidated Statement of Income)*1 Inventories as of December 31 are stated at written-down value to reflect a decline in profitability, and the following loss on valuation of inventories (gain on reversal of loss) is included in cost of sales.
FY12/24
(January 1, 2024 – December 31, 2024)
FY12/25
(January 1, 2025 – December 31, 2025)
Loss on valuation of inventories ¥152 million ¥132 million
*2 Major components and amounts of selling, general and administrative expenses are as follows.
FY12/24 (January 1, 2024 – December 31, 2024) | FY12/25 (January 1, 2025 – December 31, 2025) | |
Storage and transportation costs | ¥4,222 million | ¥4,454 million |
Salaries and allowances | 9,536 | 10,743 |
Provision for bonuses | 1,837 | 2,361 |
Retirement benefit expenses | 442 | 151 |
Research supplies expense | 5,493 | 5,635 |
Depreciation | 3,187 | 3,355 |
*3 R&D costs included in general and administrative expenses and manufacturing costs are as follows. | ||
FY12/24 (January 1, 2024 – December 31, 2024) | FY12/25 (January 1, 2025 – December 31, 2025) | |
General and administrative expenses | ¥14,379 million | ¥15,474million |
Manufacturing costs | 140 | 199 |
Total R&D costs | 14,519 | 15,673 |
*4 Gain on receipt of contingent consideration
A share transfer agreement previously entered into by the Company contained a clause stipulating that additional consideration may be received if certain conditions are met. During the fiscal year ended December 31, 2025, the Company met the conditions and received additional consideration, which was recorded in extraordinary income.
(Notes Concerning Consolidated Statement of Cash Flows)* Reconciliation between the ending balance of cash and cash equivalents and the balance in the consolidated balance sheet
FY12/24 FY12/25
(January 1, 2024 – December 31, 2024) (January 1, 2025 – December 31, 2025)
Cash and deposits ¥59,047 million ¥70,962 million Securities 999 -
Term deposits with maturities over three
months
(3,686) (1,734)
Cash and cash equivalents 56,361 69,228
(Notes Concerning Segment Information, Etc.)[Segment Information]
The Group segments its business based on products and services, with each business unit developing the comprehensive strategy on their respective products and services in Japan and overseas and conducting business activities.
The Group engages in manufacturing and sales of mainly electronic functional materials and high-purity chemicals. The disclosure is omitted as the Group operates a single business segment.
[Related Information]
Fiscal year ended December 31, 2024 (January 1, 2024 - December 31, 2024)
Information by product and service
The disclosure is omitted as the corresponding information is disclosed in Segment Information.
Information by geographic region
(1) Net sales | (Millions of yen) | |||||
Japan | Taiwan | South Korea | The U.S. | China | Other | Total |
32,539 | 68,623 | 26,314 | 19,567 | 42,770 | 11,150 | 200,966 |
Fiscal year ended December 31, 2025 (January 1, 2025 - December 31, 2025)
Information by product and service
The disclosure is omitted as the corresponding information is disclosed in Segment Information.
Information by geographic region
(1) Net sales | (Millions of yen) | |||||
Japan | Taiwan | South Korea | The U.S. | China | Other | Total |
36,638 | 85,604 | 30,447 | 24,019 | 48,611 | 11,708 | 237,029 |
FY12/24 (January 1,2024–December 31,2024) | FY12/25 (January 1,2025–December 31,2025) | |
Net assets per share | ¥1,671.82 | ¥1,898.90 |
Basic earnings per share | ¥187.29 | ¥278.42 |
Diluted earnings per share | ¥187.10 | ¥278.21 |
(Notes) 1. Basis for calculation of net assets per share is as follows.
FY12/24 (As of December 31, 2024) | FY12/25 (As of December 31, 2025) | |
Total net assets (millions of yen) | 213,473 | 242,299 |
Amount deducted from net assets (millions of yen) | 12,939 | 14,662 |
(of which, share acquisition rights) (millions of yen) | (121) | (79) |
(of which non-controlling interest) (millions of yen) | (12,818) | (14,583) |
Net assets as of year-end related to common shares (millions of yen) | 200,533 | 227,636 |
Number of common shares issued and outstanding (thousand shares) | 127,800 | 127,800 |
Number of treasury shares out of common shares (thousand shares) | 7,851 | 7,922 |
Number of common shares at year-end used to calculate net assets per share (thousand shares) | 119,948 | 119,877 |
2. Basis for calculation of basic and diluted earnings per share is as follows.
FY12/24 (January 1,2024–December 31,2024) | FY12/25 (January 1,2025–December 31,2025) | |
(1) Basic earnings per share | ||
Profit attributable to owners of parent (millions of yen) | 22,683 | 33,345 |
Amount not attributable to common shareholders (millions of yen) | — | — |
Profit attributable to owners of parent related to common shares (millions of yen) | 22,683 | 33,345 |
Average number of common shares during the period (thousand shares) | 121,108 | 119,763 |
(2) Diluted earnings per share | ||
Adjustment to profit attributable to owners of parent (millions of yen) | — | — |
Increase in number of common shares (thousand shares) | 126 | 92 |
(of which, share acquisition rights) (thousand shares) | (126) | (92) |
Dilutive shares not included in the calculation of diluted earnings per share because of their anti-dilutive effect | — | — |
(Note) The Company’s shares owned by “Tokyo Ohka Employees Stockholding Association Trust” are included in treasury shares which is excluded in the calculation of the average number of shares during the period to calculate “Basic earnings per share” and “Diluted earnings per share.” (211 thousand shares and - thousand share for the fiscal years ended December 31, 2024 and 2025, respectively).
